Study of the efficacy of fluoxetine versus tianeptine in the treatment of elderly depressed patients, followed in general practice;Etude de l'efficacite de la fluoxetine comparativement a celle de la tianeptine dans le traitement des patients ages deprimes suivis en medecine generale

Encephale

Volumn 25, Issue 3, 1999, Pages 265-270

  Guelfi, J D ^a   Bouhassira, M ^b   Bonett Perrin, E ^b   Lancrenon, S ^c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Lilly Laboratoires   (France)

^c Stat   (France)

Author keywords

Depression; Elderly; Fluoxetine; Tianeptine

Indexed keywords

FLUOXETINE; TIANEPTINE; SEROTONIN UPTAKE INHIBITOR; THIAZEPINE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; VOMITING; AMBULATORY CARE; COMPARATIVE STUDY; FOLLOW UP; HOSPITALIZATION; MAJOR DEPRESSION; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

AGED; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; PRIMARY HEALTH CARE; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; THIAZEPINES; TREATMENT OUTCOME;

EID: 0032792342     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. ALTAMURA AC, PERCUDANI M, GUERCETTI G et al. Fluoxetine compared with amitriptiline in elderly depression : a controlled clinical trial. Int J Clin Psychopharmacol 1989 ; 6 : 391-6.
2. ANSSEAU M, BATTAILE M, BRIOLE G et al. Controlled comparison of Tianeptine, Alprazolam and Mianserine in the treatment of adjustment disorders with anxiety and depression. Hum Psychopharmacol 1996 ; 11 : 293-8.
3. AUSTIN MP, ROSS M, MURRAY C. Cognitive function in major depression. J Aff Disorders 1992 ; 25 : 21-30.
4. AYALA MA, LEBLANC J. Où sont les frontières entre la dépression et la démence ? Le Clinicien 1996 : 85-96.
5. BALDWIN RC, TOMENSON B. Depression in later life, a comparison of symptoms and risk factors in early and late onset cases. Br J Psychiatry 1995 ; 167 : 649-52.
6. BLAZER DG, BACHAR JR, MANTON KG. Suicide in late life : review and commentary. J Am Geriatr Soc 1986 ; 34 : 519-25.
7. BONIN GUILLAUME S, CLEMENT JP, CHASSAIN AP et al. Psychometric evaluation of depression in the elderly subject : which instruments ? What are the future perspectives ? Encephale 1995 ; XXI : 25-34.
8. BRESSLER R, KATZM. Drug therapy for geriatric depression. Drugs and Aging 1993 ; 3 : 195-219.
9. BRINK TL. Geriatric depression scale. Clinical Gerontologist 1982 ; 11 : 37-43.
10. BRION S. Episode dépressif majeur des sujets âgés de plus de 70 ans, évaluation de l'efficacité et de l'acceptabilité de la tianeptine et de la miansérine. Presse Méd 1996 ; 25 : 461-8.
11. CARNEY MWP, ROTH M, GARSIDE RF. Newcastle : the diagnosis of depressive syndromes and the prediction of ECT response. Brit J Psychiatry 1965 ; 111 : 659-74.
12. CHAPUY P, CUNY G, DELOMIER Y, GALLEY P et al. La dépression du sujet âgé, intérêt de la tianeptine chez 140 patients traités pendant 1 an. Presse Med 1991 ; 20 : 1844-52.
13. CLEMENT JP, MARCHAN F, BOYON D et al. Utilization of the drawn of person test in the elderly. International Psychogeriatric Association 1996 ; 8 : 349-64.
14. CONSENSUS. Diagnostic et traitement de la dépression de la sénescence, JAMA (Suppl. neuropsychiatrie) 1992 ; 17 (no 254) : 15-22.
15. DESMONTES-MAINARD F, GALLEY P, MANCIET P et al. Pharmacokinetics of the antidepressant tianeptine at steady state in the elderly. J Clin Pharmacol 1991 ; 31 : 174-8.
16. DONNET A, AZORIN JM. Les pseudo-démences dépressives. L'année gérontologique 1992 ; (Suppl) : 351-7.
17. FALK WE, ROSENBAUM JF, OTTO MW et al. Fluoxetine versus trazodone in depressed geriatric patients. J Geriatr Psychiatr Neurol 1989 ; 2 : 208-14.
18. FEIGHNER JP, BOYER WF, MEREDITH CH et al. La fluoxétine dans la dépression du sujet âgé, revue de la littérature. Br J Psychiatry 1988 ; 153 (Suppl 3) : 116-20.
19. FOLSTEIN MF, FOLSTEIN SE, McHUGH Pr. Mini Mental State : a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 ; 12 : 189-98.
20. GERSON SC, PLOTKIN DA, JARVIK LF. Antidepressant drug studies, 1964 to 1986 : empirical evidence for aging patients. J Clin Psychopharmacol 1998 ; 8 : 311-22.
21. GOUDEMAND M, THOMAS P. Anxiété, dépression et démence. Rev Prat 1994 ; 44 : 1448-52.
22. GUELFI JD. Efficacy of tianeptine in comparative trials versus reference antidepressants. Br J Psychiatry 1992 ; 160 (Suppl 15) : 72-5.
23. GUY W. Clinical Global Impression. In : Assessement Manual for Psychopharmacology. National Institute of Mental Health (ed.). Rockville, Maryland, USA : Early Clinical Drug Evaluation Unit : Publication no 76-338, 1976.
24. HARRIS M, BENFIELD P. Fluoxetine : a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in older patients with depressive illness. Drugs and Aging 1995 ; 6 : 64-84.
25. HOEPFER M. Diagnosing, treating depression in the elderly. Pa Med 1995 ; 98 : 34-6.
26. JOHNSON J, SIMS R, GOTTLIEB G et al. Differential diagnosis of dementia, delirium and depression. Implications for drug therapy. Drugs and Aging 1994 ; 5 : 431-45.
27. LA PIA S, GIORGIO D, CIRIELDO R et al. Evaluation of efficacy, tolerability, and therapeutic profile of fluoxetine versus mianserine in the treatment of depressive disorders in the elderly. Current Therapeutic Research 1992 ; 52 : 847-58.
28. LACHNER G, ENGEL RR. Differentiation of dementia and depression by memory tests - A meta-analysis. J Nerv Ment Dis 1994 ; 182 : 34-9.
29. LASSER R, SIEGEL E, DUKOFF R et al. Diagnosis and Treatment of Geriatric Depression. CNS Drugs 1998 ; 9 (1) : 17-30.
30. LESHER EL, BERRYHILL JS. Validation of the geriatric depression scale. Short form among in patients. J Clin Psychology 1994 ; 50 : 256-60.
31. LOO H, DENIKER P. Position of tianeptine among antidepressive chemotherapies. Clin Neuropharmacol 1988 ; 11 (Suppl 2) : S97-102.
32. MONTFORT JC. Actualités thérapeutiques et iatropathologiques chez le sujet âgé. Psychologie Médicale 1994 ; 26 (Sp 5) : 453-6.
33. MONTGOMERY SA, ASBERG M. A New depression scale designed to be sensitive to change. Br J Psychiatry 1979 ; 134 : 382-9.
34. MONTORIO I, IZAL M. The geriatric depression scale : a review of its development and utility. Intern Psychiatr 1996 ; 8 : 103-12.
35. MULLER-SPAHN F, HOCK C. Clinical presentation of depression in the elderly. Gerontology 1994 ; 40 (Suppl 1) : 10-4.
36. NIELSEN BM, BEHNKE K, ARUP P et al. A comparison of fluoxetine and imipramine in the treatment of outpatients with major depression. J Clin Psychopharmacol 1993 ; 13 (no 6, Suppl 2) : 345-95.
37. ORENGO C. The use and tolerability of fluoxetine in gerontopsychiatric inpatients. J Clin Psychiatry 1996 ; 57 : 12-6.
38. PETIT JEAN F. L'usage des antidépresseurs chez le sujet âgé : justifications et critiques. Encephale 1995 ; XXI (Sp 1) : 55-8.
39. RIGAUD-MONNET AS, FORETTE F. Troubles psychiques des personnes âgées. Encycl Med Chir 1997 ; 37-540-A-10 : 10 p.
40. ROCKWELL E, LAM RW, ZISOOK S. Antidepressant drug studies in the elderly. Psychiatr Clin North Am 1988 ; 11 : 215-33.
41. SCHONE W, LUDWIG M. A double blind comparison of paroxetine compared with fluoxetine in geriatric patients with major depression. Eur Neuropsychopharmacol 1992 ; 2 : 301.
42. SCOTTO JC. Etude multicentrique : la fluoxétine en pratique quotidienne. Le Journal de l'Avancée Médicale 1990 : 15-7.
43. TOLLEFSON GD, BOSOMWORTH J, HEILIGENSTEIN J et al. A double blind placebo controlled clinical trial of fluoxetine in geriatric patients with major depression. International Psychogeriatrics 1995 ; 7 : 89-104.